1. Home
  2. INBK vs AKBA Comparison

INBK vs AKBA Comparison

Compare INBK & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBK
  • AKBA
  • Stock Information
  • Founded
  • INBK 1999
  • AKBA 2007
  • Country
  • INBK United States
  • AKBA United States
  • Employees
  • INBK N/A
  • AKBA N/A
  • Industry
  • INBK Major Banks
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • INBK Finance
  • AKBA Health Care
  • Exchange
  • INBK Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • INBK 363.3M
  • AKBA 336.2M
  • IPO Year
  • INBK N/A
  • AKBA 2014
  • Fundamental
  • Price
  • INBK $35.90
  • AKBA $2.37
  • Analyst Decision
  • INBK Buy
  • AKBA Strong Buy
  • Analyst Count
  • INBK 4
  • AKBA 1
  • Target Price
  • INBK $41.13
  • AKBA $7.50
  • AVG Volume (30 Days)
  • INBK 32.3K
  • AKBA 2.4M
  • Earning Date
  • INBK 01-22-2025
  • AKBA 03-13-2025
  • Dividend Yield
  • INBK 0.68%
  • AKBA N/A
  • EPS Growth
  • INBK 114.10
  • AKBA N/A
  • EPS
  • INBK 2.53
  • AKBA N/A
  • Revenue
  • INBK $108,980,000.00
  • AKBA $169,879,000.00
  • Revenue This Year
  • INBK N/A
  • AKBA N/A
  • Revenue Next Year
  • INBK $17.86
  • AKBA $30.85
  • P/E Ratio
  • INBK $14.05
  • AKBA N/A
  • Revenue Growth
  • INBK 26.53
  • AKBA N/A
  • 52 Week Low
  • INBK $24.18
  • AKBA $0.80
  • 52 Week High
  • INBK $43.26
  • AKBA $2.48
  • Technical
  • Relative Strength Index (RSI)
  • INBK 48.21
  • AKBA 75.15
  • Support Level
  • INBK $34.00
  • AKBA $1.72
  • Resistance Level
  • INBK $35.54
  • AKBA $2.00
  • Average True Range (ATR)
  • INBK 1.23
  • AKBA 0.11
  • MACD
  • INBK 0.24
  • AKBA 0.04
  • Stochastic Oscillator
  • INBK 83.52
  • AKBA 100.00

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking/treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: